$SFIX

Bacos Anthony sold $451K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 100,000 shares of Stitch Fix, Inc. (SFIX) at $4.51 ($0.45M total) on 2026-06-24 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Jun 26, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:58 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
high confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

The disclosed sale is a new, primary-source datapoint but is typically interpreted as routine when executed under a pre-arranged 10b5-1 plan, limiting fundamental read-through.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 framing suggests limited actionable impact.

03

What to watch

The article does not state whether the officer also bought shares, nor does it provide context on total compensation, tax obligations, or whether multiple tranches occurred around the same time.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-26, disclosing a sale executed 2026-06-24.

Background

This is an SEC Form 4 insider transaction disclosure for Stitch Fix, Inc. (SFIX) by an officer, including trade size, price, and 10b5-1 status.

Company-level read

Ticker impact

$SFIXNeutralHigh confidence
Context

Stitch Fix insider Form 4 shows officer Bacos Anthony sold 100,000 shares at $4.5057 on 2026-06-24 under a 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a disclosed open-market sale by an officer, explicitly under a pre-arranged Rule 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; insider sale in a single retailer does not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, large sales can coincide with internal views on near-term risk or liquidity needs, so sentiment could still wobble around the filing date.

Key entities

  • Stitch Fix, Inc.

    US-listed company whose insider sale is disclosed on Form 4.

  • Bacos Anthony

    Chief Product/Technology Officer who sold 100,000 shares.

  • Rule 10b5-1 plan

    Pre-arranged plan that generally reduces signaling value of insider sales.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.